The Conversation (0)
Reuters reported that in 2014, US drug approvals reached their highest level in 18 years. Meanwhile, recommendations in Europe also “came at a rapid rate.”
Reuters reported that in 2014, US drug approvals reached their highest level in 18 years. Meanwhile, recommendations in Europe also “came at a rapid rate.”
As quoted in the market news:
The U.S. Food and Drug Administration’s Center for Drug Evaluation and Research approved 41 novel medicines in 2014, 14 more than a year earlier, according to its website. That tally is second only to the all-time high of 53 approvals reached in 1996.
The European Medicines Agency, which includes generic drugs in its list, recommended 82 new medicines last year, up from 79 in 2013 and 57 in 2012.
